Oncology Institute (TOIIW) Long-Term Investments (2020 - 2023)

Oncology Institute has reported Long-Term Investments for 4 years, with the latest figure at $58.9 million in Q2 2023.

• For the quarter ending Q2 2023, Long-Term Investments changed N/A year-over-year to $58.9 million; the trailing twelve-month figure through Jun 2023 stood at $58.9 million (changed N/A YoY), and the FY2022 full-year result was $58.4 million, changed N/A from the prior year.
• Long-Term Investments for Q2 2023 stood at $58.9 million, roughly flat from $58.8 million in the prior quarter.
• The five-year high for Long-Term Investments was $230.3 million in Q1 2021, with the low at $58.2 million in Q3 2022.
• Historically, Long-Term Investments has averaged $161.5 million across 4 years, with a median of $230.0 million in 2021.
• Annual changes were most pronounced in 2021 — Long-Term Investments declined 0.05% — and 2022, when it slumped 74.69%.
• Oncology Institute's Long-Term Investments stood at $230.3 million in 2020, then decreased by 0.1% to $230.0 million in 2021, then tumbled by 74.63% to $58.4 million in 2022, then gained by 1.01% to $58.9 million in 2023.
• The last three Long-Term Investments figures came in at $58.9 million (Q2 2023), $58.8 million (Q1 2023), and $58.4 million (Q4 2022), per Business Quant data.